This new analysis of commercial and Medicare Advantage claims from all 50 states investigated utilization of and testing trends for coronary artery disease (CAD) among adults aged 18 and older ...
PALO ALTO, CA--(Marketwired - Mar 10, 2014) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the publication of the IMPACT-PCP (Investigation ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — In stable symptomatic patients with suspected CAD, a precision testing strategy was linked to a 70% ...
CLEVELAND, OH — The age/sex/gene-expression score (ASGES) test known as Corus CAD (CardioDx) appears easy to incorporate and effective in excluding obstructive coronary artery disease (CAD) in ...
REDWOOD CITY, CA--(Marketwired - Oct 20, 2014) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the presentation of the study, "The Use of a ...